SouthState’s Atrium Therapeutics RNA Stock Holding History
Bought
Maintained
Sold
Other funds holding RNA
AIC
SouthState's RNA Position: Q3 2026 in Review
SouthState opened a new position in Atrium Therapeutics (RNA) in Q3 2026: 2 shares worth $17. The stake represents ﹤0.01% of the portfolio and ranks #1375 among its holdings.
96 funds tracked by Wall St. Rank hold RNA as of Q3 2026.
- SouthState held 2 shares of Atrium Therapeutics worth $17 as of Q3 2026.
- Atrium Therapeutics was a new SouthState position in Q3 2026.
- Atrium Therapeutics made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1375 holding.
- 96 funds tracked by Wall St. Rank held Atrium Therapeutics as of Q3 2026.
Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.